Purple Net Interest Income from 2010 to 2026
| PPBT Stock | USD 0.61 0.01 1.00% |
Net Interest Income | First Reported 2010-12-31 | Previous Quarter -190.8 K | Current Value -181.3 K | Quarterly Volatility 496.7 K |
Check Purple Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Purple Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 159.9 K, Interest Expense of 298.6 K or Selling General Administrative of 4.6 M, as well as many indicators such as Price To Sales Ratio of 92.33, Dividend Yield of 0.088 or PTB Ratio of 0.48. Purple financial statements analysis is a perfect complement when working with Purple Biotech Valuation or Volatility modules.
Purple | Net Interest Income | Build AI portfolio with Purple Stock |
The evolution of Net Interest Income for Purple Biotech provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Purple Biotech compares to historical norms and industry peers.
Latest Purple Biotech's Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Purple Biotech over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Purple Biotech's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Purple Biotech's overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Purple Net Interest Income Regression Statistics
| Arithmetic Mean | (47,827) | |
| Coefficient Of Variation | (1,039) | |
| Mean Deviation | 285,756 | |
| Median | 77,000 | |
| Standard Deviation | 496,718 | |
| Sample Variance | 246.7B | |
| Range | 2.5M | |
| R-Value | (0.28) | |
| Mean Square Error | 242.5B | |
| R-Squared | 0.08 | |
| Significance | 0.28 | |
| Slope | (27,543) | |
| Total Sum of Squares | 3.9T |
Purple Net Interest Income History
About Purple Biotech Financial Statements
Purple Biotech shareholders use historical fundamental indicators, such as Net Interest Income, to determine how well the company is positioned to perform in the future. Although Purple Biotech investors may analyze each financial statement separately, they are all interrelated. The changes in Purple Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses on on Purple Biotech's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -190.8 K | -181.3 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Purple Stock Analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.